Canine Kidney Tumor Study Guide

Overview and Clinical Importance

Primary renal neoplasia is uncommon in dogs, accounting for less than 1.7% of all canine tumors. However, these tumors are clinically significant due to their highly malignant nature, with over 90% being malignant. The majority are epithelial in origin, with renal cell carcinoma (RCC) being the most common primary renal tumor in dogs. Understanding the classification, diagnosis, and management of canine kidney tumors is essential for NAVLE success, particularly recognizing breed predispositions and the critical role of early surgical intervention.

Epidemiology and Risk Factors

Patient Demographics

Primary renal tumors predominantly affect middle-aged to older dogs, with a mean age of 8.1 years (range 1-17 years). There is a male predisposition, with males being affected approximately 50% more commonly than females. Medium to large breed dogs (mean weight 24.9 kg) are most commonly affected. The exception is nephroblastoma, which typically affects dogs less than 12 months of age.

Patient Demographics by Tumor Type

Classification of Canine Renal Tumors

Renal tumors can be classified by their tissue of origin and whether they are primary, metastatic, or multicentric. Over 85% of primary renal tumors are epithelial in origin.

Primary Renal Tumor Classification

Board Tip - Memory Aid: "RENTS" for Renal Tumor Types = RCC (Renal Cell Carcinoma), Embryonal (Nephroblastoma), "N" for No-metastatic benign tumors, TCC (Transitional Cell Carcinoma), Sarcomas (mesenchymal). Remember: EPITHELIAL tumors are most common (greater than 85%)!

Renal Cell Carcinoma (RCC)

Renal cell carcinoma is the most common primary malignant renal tumor in dogs, originating from the renal tubular epithelium. It is typically unilateral, located at one pole of the kidney, and well-demarcated. Size varies from microscopic to several times the normal kidney size.

Pathology and Behavior

RCC is classified histologically as solid, tubular, or papillary, though most exhibit a mixed pattern. These tumors are highly malignant with early metastasis. A critical complication is invasion of the caudal vena cava and tributary veins with development of tumor thrombus, which complicates surgical treatment.

Metastatic Pattern

Paraneoplastic Syndromes

Polycythemia is a reported paraneoplastic syndrome seen with renal tumors, particularly RCC. This occurs due to excessive secretion of erythropoietin by the tumor. The proximal convoluted tubule is the main site of erythropoietin production, and most renal carcinomas involve this area. Neutrophilic leukocytosis is another paraneoplastic syndrome associated with renal tumors.

German Shepherd Renal Cystadenocarcinoma and Nodular Dermatofibrosis (RCND)

This is a hereditary cancer syndrome unique to German Shepherd Dogs, representing approximately 6% of all kidney tumors in the breed. It is caused by a mutation in the FLCN (folliculin) gene (c.764A>G mutation in exon 7) and is inherited in an autosomal dominant pattern with complete penetrance. This syndrome is analogous to Birt-Hogg-Dubé syndrome in humans.

Clinical Triad

Nephroblastoma (Wilms Tumor)

Nephroblastoma is an uncommon congenital tumor originating from the metanephric blastema, resulting from abnormal differentiation of the kidney during embryogenesis. It is a mixed tumor consisting of blastemal, epithelial, and mesenchymal components in various stages of differentiation. While typically affecting young dogs (less than 12 months), it has been reported in dogs up to 12 years old.

Histologic Grading (National Wilms Tumor Study Group)

Ectopic (Spinal Cord) Nephroblastoma

Nephroblastoma can also occur in the thoracolumbar spinal cord (T9-L2), arising from remnants of metanephric tissue located between the dura mater and spinal cord. This presentation is most common in young, large breed dogs, with an overrepresentation of German Shepherd Dogs. Clinical signs include chronic, progressive T3-L3 myelopathy. Diagnosis is confirmed by immunohistochemistry with positive WT-1 (Wilms tumor-1) staining.

Clinical Presentation

Clinical signs of renal neoplasia are often nonspecific and vague, frequently not manifesting until the disease is advanced. Tumors can become very large before detection.

Clinical Signs by Frequency

Diagnostic Approach

Laboratory Findings

Diagnostic Imaging

Abdominal ultrasound is the preferred initial imaging modality and enables earlier diagnosis. Renal tumors typically produce mixed echogenicity with disruption of normal renal architecture. Lymphoma is the exception, often appearing diffuse and hypoechoic.

Imaging Modalities Comparison

Tissue Diagnosis

Histopathologic examination is required for definitive diagnosis and tumor type determination. Fine needle aspiration (FNA) with ultrasound guidance is useful, particularly for diagnosing renal lymphoma (78% diagnostic on first attempt). For unilateral lesions, surgical biopsy with simultaneous staging and treatment (nephrectomy) is preferred. Percutaneous biopsy carries risks of minor hemorrhage, microscopic hematuria, and potential tumor seeding.

Treatment

Nephrectomy (surgical removal of the affected kidney and ureter) is the treatment of choice for all primary renal tumors except lymphoma. Prior to surgery, the function of the remaining kidney must be evaluated using blood tests, excretory urography, or nuclear scintigraphy.

Treatment by Tumor Type

Prognosis and Survival

Board Tip - Memory Aid: "MITOTIC index is the MOST important prognostic factor for renal carcinoma." Low MI (less than 10) = better prognosis (greater than 3 years possible). High MI (greater than 30) = poor prognosis (approximately 6 months).

Key Differentials for Renal Masses

• Primary renal neoplasia: RCC, TCC, sarcomas, nephroblastoma
• Metastatic neoplasia: Hemangiosarcoma, osteosarcoma, melanoma, mast cell tumor, various carcinomas
• Multicentric neoplasia: Lymphoma (most common), histiocytic sarcoma
• Non-neoplastic: Renal cysts, hydronephrosis, abscess, hematoma, granuloma, polycystic kidney disease